These findings are in agreement with previous research, which has highlighted the influence of genetic polymorphisms in interferon-related genes (e.g., IFNAR2, OAS3, OAS1) on immune response modulation and disease outcomes in COVID-19 [124,125,126,127,128]. The gene discussed is OAS1; the disease is COVID-19.